Korro Bio, Inc. (NASDAQ:KRRO) Receives $142.17 Average Price Target from Brokerages
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings firms that are covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price […]
More Stories
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...